Transcultural Aspects of Depressive Symptomatology

C. Perris(Umeå University), L Vacca(University of Naples Federico II), D. Kemali, Martin Eisemann(OsloMet – Oslo Metropolitan University), Michele Del Vecchio(Fondazione IRCCS Istituto Nazionale dei Tumori), H. Perris(Umeå University), A. Amati, Urban Eriksson(Umeå University)

Psychiatria Clinica

February 5, 2010

10.1159/000283904

Cited by 9

Related Papers

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma

|New England Journal of Medicine|2017|2.2k

Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial

|The Lancet Oncology|2017|780

Interleukin-12: Biological Properties and Clinical Application

|Clinical Cancer Research|2007|606

Adjuvant nivolumab versus ipilimumab in resected stage IIIB–C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial

|The Lancet Oncology|2020|530

Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial

|The Lancet Oncology|2017|501